Overview
- Use of Brainomix 360 Stroke was linked to a median 64‑minute reduction in door‑in door‑out transfer time at primary stroke centres.
- Thrombectomy rates at evaluation hospitals rose from 2.3% to 4.6%, compared with a smaller increase from 1.6% to 2.6% at non‑evaluation sites.
- Patients reviewed with the AI were more likely to receive endovascular thrombectomy (OR 1.57) and intravenous thrombolysis (OR 1.99), with better discharge outcomes and no rise in in‑hospital mortality.
- The study drew on SSNAP audit data from 452,952 stroke patients across 107 hospitals, including 71,017 ischemic strokes at 26 evaluation sites and 15,377 patients whose scans were AI‑reviewed.
- Benefits were most pronounced at hospitals without on‑site neuroradiology, the platform is now in use at more than 70 NHS hospitals, and authors note limits such as selection differences and a need for broader 24/7 thrombectomy capacity.